Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A phase 2, single-center, randomized controlled trial

Cancer

Volumn 120, Issue 22, 2014, Pages 3502-3509

  Tian, Yun ming ^a   Zhao, Chong ^b   Guo, Ying ^b   Huang, Ying ^b   Huang, Shao Min ^b   Deng, Xiao Wu ^b   Lin, Cheng Guang ^b   Lu, Tai xiang ^b   Han, Fei ^b  

^a Department of Radiation Oncology   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

fraction size; intensity modulated radiotherapy (IMRT); late complications; local recurrence; nasopharyngeal carcinoma; total dose

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; CRANIAL NEUROPATHY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; FRACTION SIZE; HEARING IMPAIRMENT; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MUCOSAL NECROSIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RE-IRRADIATION; TREATMENT DURATION; TREATMENT FAILURE; TRISMUS; TUMOR VOLUME; XEROSTOMIA;

EID: 85006379862     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28934     Document Type: Article

References (28)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-429.
2. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041-2054.
3. Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261-270.
4. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
5. Chua DT, Sham JS, Kwong PW, et al. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys. 2003;56:177-183.
6. Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hematol. 2000;33:91-98.
7. Law SC, Lam WK, Ng MF, et al. Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage. Int J Radiat Oncol Biol Phys. 2002;54:1095-1113.
8. Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993;26:773-782.
9. Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 1998;40:897-913.
10. Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional 3-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:638-647.
11. Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682-687.
12. Chua DT, Sham JS, Leung LH, Au GK. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005;77:290-294.
13. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma–treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987;13:953-956.
14. Lee AW, Foo W, Law SC, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys. 1997;38:43-52.
15. Chang JT, See LC, Liao CT, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000;54:135-142.
16. Oksuz DC, Meral G, Uzel O, et al. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys. 2004;60:388-394.
17. Qiu S, Lin S, Tham IW, et al. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;83:676-683.
18. Han F, Zhao C, Huang SM, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2012;24:569-576.
19. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39:115-126.
20. Schwaibold F, Scariato A, Nunno M, et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys. 1988;14:451-454.
21. Li JC, Hu CS, Jiang GL, et al. Dose escalation of 3-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma: a prospective randomised study. Clin Oncol (R Coll Radiol). 2006;18:293-299.
22. Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys. 1988;15:575-579.
23. Zheng XK, Ma J, Chen LH, et al. Dosimetric and clinical results of 3-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2005;75:197-203.
24. Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283-288.
25. Hua YJ, Chen MY, Qian CN, et al. Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck. 2009;31:807-812.
26. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310-1317.
27. Chua DT, Sham JS, Au GK. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. Am J Clin Oncol. 2005;28:464-471.
28. Poon D, Yap SP, Wong ZW, et al. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1312-1318.